Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant

NCT05311228 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT05311228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05311228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant
Lead sponsor
Indonesia University
Phase
Phase 4
Overall status
Completed
Start date
June 8, 2021
Completion date
April 1, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis